iBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference
Yahoo Finance · Sep 1, 2026 · iBio, Inc. Common Stock (IBIO)
SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ: IBIO), a clinical-stage biotechnology company developing long-acting antibody therapeutics for obesity, cardiometabolic and cardiopulmonary diseases, today announced that it will participate in the Wells Fargo 21st Annual Healthcare Conference, taking place September 8-10, 2026, in Boston. Martin Brenner, DVM, Ph.D., Chief Executive Officer and Chief Scientific Officer of iBio, will participate in a fireside chat on Tuesday, Septe
Not investment advice. Cached headline, not a full reprint.